Serum IL-23 levels reflect a myeloid inflammatory signature and predict the response to apremilast in patients with psoriatic arthritis.

Front Immunol · 2024 · PMC11652657 · PMID 39697337

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

However, during the 4-month follow-up, only the expression of IL-23 showed a trend toward a decrease in responders ( Figure 2 ; Supplementary Table S3 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.